Moxalid (Meloxicam)

Meloxicam, the active ingredient in Moxalid, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal conditions.

GNH USA supplies Moxalid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics across global markets. The company adheres to stringent manufacturing standards and provides comprehensive support for product registration and post‑marketing surveillance.

Meloxicam is used to manage inflammatory and painful conditions within the musculoskeletal disease spectrum.

- Osteoarthritis: reduces joint pain and improves functional mobility. - Rheumatoid arthritis: alleviates chronic inflammation and joint damage progression. - Ankylosing spondylitis: diminishes spinal stiffness and pain. - Acute musculoskeletal pain: provides rapid relief of pain associated with sprains, strains or injuries.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Edema: peripheral swelling, especially of the ankles. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe hypersensitivity reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: increased risk of myocardial infarction or stroke.

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic enzymes: use cautiously in liver disease. - Evaluate cardiovascular risk: consider alternatives in patients with established heart disease. - Use lowest effective dose: limit duration to the shortest period necessary. - Avoid in hypersensitivity: discontinue if signs of allergic reaction appear. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance nephrotoxic effects. - Lithium: meloxicam can raise lithium serum levels. - Methotrexate: potential for increased toxicity at high doses.